Effects of IgY against Candida albicans and Candida spp. adherence and biofilm formation

DOI Web Site Web Site
  • Fujibayashi Taisuke
    Dentistry for Persons with Disabilities, Tokyo Medical and Dental University, Japan Department of Bacteriology I, National Institute of Infectious Diseases, Japan
  • Nakamura Moriyuki
    Dentistry for Persons with Disabilities, Tokyo Medical and Dental University, Japan Department of Bacteriology I, National Institute of Infectious Diseases, Japan
  • Tominaga Akira
    Oral Surgery, Tokyo Medical University, Japan Department of Bacteriology I, National Institute of Infectious Diseases, Japan
  • Satoh Norifumi
    EN Otsuka Pharmaceutical Co. Ltd R&D Laboratories, Japan
  • Kawarai Taketo
    Department of Bacteriology I, National Institute of Infectious Diseases, Japan
  • Narisawa Naoki
    Department of Bacteriology I, National Institute of Infectious Diseases, Japan
  • Shinozuka Osamu
    Dentistry for Persons with Disabilities, Tokyo Medical and Dental University, Japan
  • Watanabe Haruo
    Department of Bacteriology I, National Institute of Infectious Diseases, Japan
  • Yamazaki Tsuneyoshi
    Dentistry for Persons with Disabilities, Tokyo Medical and Dental University, Japan
  • Senpuku Hidenobu
    Department of Bacteriology I, National Institute of Infectious Diseases, Japan

書誌事項

タイトル別名
  • Effects of IgY against <i>Candida albicans</i> and <i>Candida</i> spp. Adherence and Biofilm Formation

この論文をさがす

抄録

<p>The fungal pathogen Candida albicans is an opportunistic fungal pathogen that causes oral and vaginal mucosal infections as well as systemic disease. The ability of C. albicans to adhere to host surfaces is positively correlated with its pathogenicity. We prepared a polyclonal anti-Candida albicans antibody in chicken egg yolk (anti-C. albicans IgY) and investigated its in vitro effectiveness in preventing C. albicans adherence and biofilm formation. Anti-C. albicans IgY significantly reduced the adherence of C. albicans SC5314 to human oral epithelial cells in a dose-dependent manner. The same effect was also observed in other Candida spp. including C. albicans serotype A and B. Further, the IgY inhibited biofilm formation of C. albicans in medium without serum, but the inhibition was slightly restored in medium conditioned with 10% serum. The data indicate that anti-C. albicans IgY cross-reacted with various Candida spp. and may have a protective effect against oral candidiasis and reduce the dissemination of Candida spp. This effect may be due to the blocking of the binding of Candida spp. to the host cells. However, the blocking did not play a role when Candida formed a germ tube in the presence of serum. Therefore, anti-C. albicans IgY may be considered as a prophylactic immunotherapy or possibly an adjunctive antifungal therapy under limited conditions.<tt> </tt></p>

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ